A comaprative study to determine the safety and efficacy of Autologous Human Platelet Lysate (HPL) in treatment of Dark Circles
Phase 1
Completed
- Conditions
- Health Condition 1: null- Periorbital Hyperpigmentation (Dark Circles)
- Registration Number
- CTRI/2012/04/002549
- Lead Sponsor
- KASIAK RESEARCH PRIVATE LIMITED
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
1.Subjects (male and female), aged 18 to 55 years (both inclusive) with Periorbital Hyperpigmentation.
2.Subject willing to refrain from any other treatment of Periorbital Hyperpigmentation during entire study duration.
3.Subjects who are willing to give informed consent and adhere to the study protocol.
Exclusion Criteria
1.Subjects aged less than 18 and more than 55 years
2.Subjects with history of connective tissue disease.
3. Subjects with metabolic or hematopoietic disorders
4. Subjects unwilling to or unable to comply with the study protocol.
5. Subjects taking concomitant therapy that might interfere with the study results in the investigatorâ??s opinion or participating in another trial in the past 30 days.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method